Use of Highly Active Antiretroviral Therapy in a Cohort of HIV-Seropositive Women

Abstract

After the penetration of HAART into this cohort, additional differences emerged between HAART users and nonusers. These findings can inform public health efforts to enhance women' access to the most effective types of therapy.